Robert Allen Coleman

Prof. Dr. Robert Allen Coleman

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
LCLuis A. Carvajal
Luis A. Carvajal
DNDaniela Ben Neriah
Daniela Ben Neriah
ASAdrien Senecal
Adrien Senecal
LBLumie Benard
Lumie Benard
VTVictor Thiruthuvanathan
Victor Thiruthuvanathan
USUlrich Steidl
Ulrich Steidl
Dual inhibition of MDMX and MDM2 by an α-helical p53-stapled peptide (ALRN-6924) results in robust antitumor activity in acute myeloid leukemia.

1 January 2017 in Molecular Imaging
Verified
Journal Article
Open access
RCRobert Allen Coleman
Robert Allen Coleman
CLChristopher Liang
Christopher Liang
RPRima Patel
Rima Patel
SASarah Ali
Sarah Ali
Jogeshwar MukherjeeJogeshwar Mukherjee
Jogeshwar Mukherjee
Objective: Imaging animal models of Alzheimer disease (AD) is useful for the development of therapeutic drugs and understanding AD. Transgenic Swedish hAPPswe Tg2576 mice are a good model of β-amyloid plaques. We report 18F-fluoro-2-deoxyglucose (18F-FDG) positron emission tomography (PET) imaging of brain and intrascapular brown adipose tissue (IBAT) in transgenic mice 2576 (Tg2576) and wild-type (WT) mice. Methods: Transgenic Tg2576 mice and WT mice, >18 months were injected intraperitonally with ≈ 25 to 30 MBq 18F-FDG while awake. After 60 minutes, they were anesthetized with isoflurane (2.5%) and imaged with Inveon MicroPET. Select mice were killed, imaged ex vivo, and 20 µm sections cut for autoradiography. 18F-FDG uptake in brain and IBAT PET and brain autoradiographs were analyzed. Results: Fasting blood glucose levels averaged 120 mg/dL for WT and 100 mg/dL for Tg2576. Compared to WT, Tg2576 mice exhibited a decrease in SUVglc in the various brain regions. Average reductions in the cerebrum regions were as high as −20%, while changes in cerebellum were −3%. Uptake of 18F-FDG in IBAT decreased by −60% in Tg2576 mice and was found to be significant. Intrascapular brown adipose tissue findings in Tg2576 mice are new and not previously reported. Use of blood glucose for PET data analysis and corpus callosum as reference region for autoradiographic analysis were important to detect change in Tg2576 mice. Conclusion: Our results suggest that 18F-FDG uptake in the Tg2576 mice brain show 18F-FDG deficits only when blood glucose is taken into consideration.

1 February 2020 in Cell Reports
Verified
Journal Article
Open access
WDWilliam C. Drosopoulos
William C. Drosopoulos
DVDavid A. Vierra
David A. Vierra
CKCharles A. Kenworthy
Charles A. Kenworthy
RCRobert Allen Coleman
Robert Allen Coleman
CSCarl Schildkraut
Carl Schildkraut
Human DNA polymerase delta (Pol δ) forms a holoenzyme complex with the DNA sliding clamp proliferating cell nuclear antigen (PCNA) to perform its essential roles in genome replication. Here, we utilize live-cell single-molecule tracking to monitor Pol δ holoenzyme interaction with the genome in real time. We find holoenzyme assembly and disassembly in vivo are highly dynamic and ordered. PCNA generally loads onto the genome before Pol δ. Once assembled, the holoenzyme has a relatively short lifetime on the genome, implying multiple Pol δ binding events may be needed to synthesize an Okazaki fragment. During disassembly, Pol δ dissociation generally precedes PCNA unloading. We also find that Pol δ p125, the catalytic subunit of the holoenzyme, is maintained at a constant cellular level, indicating an active mechanism for control of Pol δ levels in vivo. Collectively, our studies reveal that Pol δ holoenzyme assembly and disassembly follow a predominant pathway in vivo; however, alternate pathways are observed.

1 July 2017 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
RCRobert Allen Coleman
Robert Allen Coleman
ZQZ. Qiao
Z. Qiao
SSS. K. Singh
S. K. Singh
CPC. S. Peng
C. S. Peng
MCM. Cianfrocco
M. Cianfrocco
WLW. L. Liu
W. L. Liu
P53 is a central regulator that turns on vast gene networks to maintain cellular integrity in the presence of various stimuli. p53 activates transcription initiation in part by aiding recruitment of TFIID to the promoter. However, the precise means by which p53 dynamically interacts with TFIID to facilitate assembly on target gene promoters remains elusive. To address this key issue, we have undertaken an integrated approach involving single-molecule fluorescence microscopy, single-particle cryo-electron microscopy, and biochemistry. Our real-time single-molecule imaging data demonstrate that TFIID alone binds poorly to native p53 target promoters. p53 unlocks TFIID9s ability to bind DNA by stabilizing TFIID contacts with both the core promoter and a region within p539s response element. Analysis of single-molecule dissociation kinetics reveals that TFIID interacts with promoters via transient and prolonged DNA binding modes that are each regulated by p53. Importantly, our structural work reveals that TFIID9s conversion to a rearranged DNA binding conformation is enhanced in the presence of DNA and p53. Notably, TFIID9s interaction with DNA induces p53 to rapidly dissociate, which likely leads to additional rounds of p53-mediated recruitment of other basal factors. Collectively, these findings indicate that p53 dynamically escorts and loads TFIID onto its target promoters.

18 March 2013 in Synapse
Verified
Journal Article
Open access
PDF file
NSNeil Saigal
Neil Saigal
ABAlisha K. Bajwa
Alisha K. Bajwa
SFSara S. Faheem
Sara S. Faheem
RCRobert Allen Coleman
Robert Allen Coleman
SPSuresh K. Pandey
Suresh K. Pandey
Jogeshwar MukherjeeJogeshwar Mukherjee
Jogeshwar Mukherjee
Introduction Serotonin 5‐HT1A receptors have been investigated in various CNS disorders, including epilepsy, mood disorders, and neurodegeneration. [18F]Mefway (N‐{2‐[4‐(2′‐methoxyphenyl)piperazinyl]ethyl}‐N‐(2‐pyridyl)‐N‐(cis/trans−4′‐[18F]fluoromethylcyclohexane)‐carboxamide) has been developed as a suitable positron emission tomography (PET) imaging agent for these receptors. We have now evaluated the suitability of [18F]trans‐mefway in rat and mouse models using PET and computerized tomography (CT) imaging and corroborated with ex vivo and in vitro autoradiographic studies. Methods Normal Sprague–Dawley rats and Balb/C mice were used for PET/CT imaging using intravenously injected [18F]trans‐mefway. Brain PET data were coregistered with rat and mouse magnetic resonance imaging template and regional distribution of radioactivity was quantitated. Selected animals were used for ex vivo autoradiographic studies to confirm regional brain distribution and quantitative measures of binding, using brain region to cerebellum ratios. Binding affinity of trans‐mefway and WAY‐100635 was measured in rat brain homogenates. Distribution of [18F]trans−4‐fluoromethylcyclohexane carboxylate ([18F]FMCHA), a major metabolite of [18F] trans‐mefway, was assessed in the rat by PET/CT. Results The inhibition constant, Ki for trans‐mefway was 0.84 nM and that for WAY‐100635 was 1.07 nM. Rapid brain uptake of [18F]trans‐mefway was observed in all rat brain regions and clearance from cerebellum was fast and was used as a reference region in all studies. Distribution of [18F]trans‐mefway in various brain regions was consistent in PET and in vitro studies. The dorsal raphe was visualized and quantified in the rat PET but identification in the mouse was difficult. The rank order of binding to the various brain regions was hippocampus > frontal cortex > anterior cingulate cortex > lateral septal nuclei > dorsal raphe nuclei. Conclusion [18F]trans‐Mefway appears to be an effective 5‐HT1A receptor imaging agent in rodents for studies of various disease models. Synapse 67:596–608, 2013.

30 March 2022 in Biophysical Journal
Verified
Journal Article
Open access
CKCharles A. Kenworthy
Charles A. Kenworthy
NHNayem Haque
Nayem Haque
SLShu-Hao Liou
Shu-Hao Liou
PCPanagiotis Chandris
Panagiotis Chandris
VWVincent Wong
Vincent Wong
RCRobert Allen Coleman
Robert Allen Coleman
Chromatin remodelers actively target arrays of acetylated nucleosomes at select enhancers and promoters to facilitate or shut down the repeated recruitment of RNA polymerase II during transcriptional bursting. It is poorly understood how chromatin remodelers such as PBAF dynamically target different chromatin states inside a live cell. Our live-cell single-molecule fluorescence microscopy study reveals chromatin hubs throughout the nucleus where PBAF rapidly cycles on and off the genome. Deletion of PBAF’s bromodomains impairs targeting and stable engagement of chromatin in hubs. Dual color imaging reveals that PBAF targets both euchromatic and heterochromatic hubs with distinct genome-binding kinetic profiles that mimic chromatin stability. Removal of PBAF’s bromodomains stabilizes H3.3 binding within chromatin, indicating that bromodomains may play a direct role in remodeling of the nucleosome. Our data suggests that PBAF’s dynamic bromodomain-mediated engagement of a nucleosome may reflect the chromatin-remodeling potential of differentially bound chromatin states.